clarithromycin has been researched along with Body Weight in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, RN; Feng, LN; Guan, JL; Han, YY; Li, JY; Li, PY; Liao, JZ; Wang, MR; Xia, SH; Zhang, MY; Zhang, Y; Zhao, K | 1 |
| Kimko, H; Mannaert, E; Mould, DR; Thyssen, A; Treem, WR | 1 |
| Cho, YJ; Heo, RW; Jeong, YY; Kang, KM; Lee, JD; Lee, SJ; Roh, GS; Song, DH; Yi, CO | 1 |
| Inoue, H; Ito, M; Kasai, C; Moritani, I; Oya, Y; Shiraki, K; Sugimoto, K; Takase, K; Takei, Y; Tameda, M; Tanaka, J | 1 |
| Donovan, JL; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P | 1 |
| Bowlus, CL; Date, Y; Hoshino, H; Ishino, Y; Kita, H; Nakazato, M; Ohnishi, H; Osawa, H; Satoh, K; Shiiya, T; Sugano, K; Ueno, H; Watanabe, E | 1 |
| Brown, RD; Germolec, DR; Karrow, NA; McCay, JA; Musgrove, DL; White, KL | 1 |
| Cao, G; Devcich, KJ; Guay, DR; Gustavson, LE; Olson, CA; Zhang, J | 1 |
| Fukuda, Y; Imakita, M; Kurokawa, M; Shiraki, K; Tsurita, M; Watanabe, Y | 1 |
| Hamada, K; Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Narita, N; Sakamoto, M | 1 |
3 trial(s) available for clarithromycin and Body Weight
| Article | Year |
|---|---|
Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study.
Topics: Adult; Body Mass Index; Body Weight; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Placebos; Ranitidine; Treatment Outcome | 2011 |
Pharmacokinetics and tolerability of extended-release clarithromycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Weight; Bronchitis; Clarithromycin; Delayed-Action Preparations; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Racial Groups | 2001 |
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Topics: Aged; Biomarkers; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Combined Modality Therapy; Disease Progression; Female; Humans; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Protein Synthesis Inhibitors; Survival Analysis; Treatment Outcome; Weight Gain | 2001 |
7 other study(ies) available for clarithromycin and Body Weight
| Article | Year |
|---|---|
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Body Size; Body Weight; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen.
Topics: Adolescent; Amoxicillin; Area Under Curve; Body Weight; Child; Child, Preschool; Clarithromycin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Proton Pump Inhibitors; Rabeprazole | 2015 |
Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice.
Topics: Animals; Apoptosis; Body Weight; Clarithromycin; Disease Models, Animal; Female; Fibrosis; Lung; Mice; Mice, Inbred C57BL; Radiation Pneumonitis; Radiation-Protective Agents | 2015 |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Body Mass Index; Body Weight; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis, Atrophic; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leptin; Male; Middle Aged; Peptic Ulcer | 2016 |
Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure.
Topics: Amoxicillin; Anti-Bacterial Agents; Biomarkers; Biopsy; Body Weight; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Follow-Up Studies; Gastric Mucosa; Gastritis; Gene Expression; Ghrelin; Growth Hormone; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Middle Aged; Peptide Hormones; Prognosis; Proton Pump Inhibitors; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Evaluation of the immunomodulatory effects of the macrolide antibiotic, clarithromycin, in female B6C3F1 mice: a 28-day oral gavage study.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antibody Formation; Antibody-Producing Cells; Blood Cell Count; Body Weight; Clarithromycin; Dose-Response Relationship, Drug; Female; Immunoglobulin M; Intubation, Gastrointestinal; Killer Cells, Natural; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred Strains; Organ Size; Spleen; T-Lymphocytes, Cytotoxic; Toxicity Tests | 2001 |
Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.
Topics: Administration, Intranasal; Administration, Oral; Animals; Anti-Bacterial Agents; Body Weight; Clarithromycin; Dogs; Female; Interleukin-12; Mice; Mice, Inbred DBA; Orthomyxoviridae; Orthomyxoviridae Infections; Recombinant Proteins; Survival Rate | 2001 |